2028年までの北米血尿治療市場予測 - 新型コロナウイルス感染症の影響と治療(薬剤、治療法、その他)、適応症(尿路感染症、腎臓結石、尿道炎、血液がん、膀胱結石、前立腺がん、膀胱炎、外傷)別の地域分析、激しい運動、多発性嚢胞腎、子宮内膜症、月経)、タイプ(肉眼的血尿、顕微鏡的血尿、特発性血尿、ジョガー血尿)、エンドユーザー(病院、診療所、外来手術センターなど)

TIPRE00026252 | Pages: 158 | Pharmaceuticals | Dec 2021 | Type: Regional | Status: Published

市場紹介

血尿は、尿中に血液が認められる病状です。 。一般に、尿には赤血球が含まれていないため、腎臓結石、尿路感染症、その他の遺伝性疾患を引き起こす可能性のある深刻な問題が発生する可能性があります。

さらに、血尿の有病率が高いため、関連する兆候は、予測期間中に市場の成長を促進すると予想されます。しかし、関連する適応症の未診断の症例は、北米の血尿治療市場の成長を制限しています。

パンデミックは、腎臓病市場で事業を展開するプレーヤーにとって重要な成長の機会を提供しました。その可能性は、コロナウイルスの影響を受ける患者数の増加によるものでした。例えば、米国腎臓学会の報告書によると、新型コロナウイルス感染症への対応として、集中治療室(ICU)に入院したコロナウイルス陽性患者の半数が、何らかの透析を必要とする腎不全を経験しているという。報告書によると、ICU にいる患者の約 10% ~ 50% が腎不全を示し、患者のほぼ 17% が緊急透析を必要とし、46% が何らかの形の急性腎障害 (AKI) を示したと述べています。北米地域全体で、米国はコロナウイルスの影響を受ける患者数が最も多く記録されている。したがって、患者数の増加により、敗血症性ショックを伴う尿細管損傷、微小炎症、血液凝固の増加、および腎臓の直接感染の可能性を含む、急性腎損傷(AKI)に罹患するリスクが高くなります。したがって、腎疾患管理製品の需要が高まり、今後の市場の成長につながると予想されます。

市場の概要とダイナミクス >

北米の血尿治療市場は、2021 年の 3 億 5,160 万米ドルから 2028 年までに 4 億 1,970 万米ドルに達すると予測されています。 2021 年から 2028 年にかけて 2.6% の CAGR で成長すると予想されています。医療機器や診断手順の技術開発により、腎臓結石、膀胱結石、尿路感染症などの血尿に関連する適応症を管理するためのさまざまな選択肢が生まれています。先進的な治療技術の利用により、患者ケアの向上が期待されています。たとえば、尿路結石症の治療のための手術におけるロボット工学の導入は、近年人気を集めています。現在、Intuitive Surgical Inc. の Vinci Surgical System は、尿路結石症の治療手術に広く使用されています。同様に、腎臓結石に対する内科学的介入の受け入れは、さまざまな国で大幅に増加しています。また、関連適応症の進歩が予測期間中に北米の血尿治療市場を支援すると予想されます。

主要市場セグメント >

タイプの点では、肉眼的血尿セグメントが 2020 年の北米血尿治療市場で最大のシェアを占めました。 2020年の北米血尿治療市場では、尿路感染症セグメントが最大のシェアを占めました。適応症に関しては、尿路感染症セグメントが2020年の北米血尿治療市場で最大のシェアを占めました。エンドユーザーに関しては、病院セグメントがトップでした。 2020 年の北米血尿治療市場で最大のシェアを占めました。

リストされている主要な供給源と企業

北米の血尿治療市場に関するこのレポートを作成するために参照したいくつかの主要な一次および二次情報源は、企業の Web サイト、年次報告書、財務報告書、政府文書、および統計データベースです。 、とりわけ。報告書に記載されている主要企業は、アストラゼネカ、ブリストル・マイヤーズ スクイブ社、F. ホフマン・ラ・ロッシュ社、グラクソ・スミスクライン社、ヤンセン・ファーマシューティカルズ社、メルク・アンド・ヘルスケア社などです。 Co., Inc.、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd、および Boehringer Ingelheim International GmbH。

レポートを購入する理由

  • 北米の血尿治療市場の状況を理解し、市場セグメントを特定するため高い収益が保証される可能性が高い
  • 絶えず変化する市場環境を理解し、競争で優位に立つため
  • 最も売上が見込めるセグメントを特定することで、北米血尿治療市場における合併・買収およびパートナーシップ取引を効率的に計画する
  • 洞察力のある包括的な分析から、知識に基づいたビジネス上の意思決定を行うさまざまなセグメントの市場パフォーマンス
  • 2021~2028年のさまざまなセグメントに基づいた北米血尿治療市場の市場収益予測を取得するため

北米血尿治療市場セグメンテーション

作成者 治療

  • 薬物
  • 治療法
  • その他

適応症別

  • 尿路感染症
  • 腎臓結石
  • 尿道炎
  • 血液がん
  • 膀胱結石
  • 前立腺がん
  • 膀胱炎
  • 外傷
  • 激しい運動
  • 多発性嚢胞腎
  • 子宮内膜症
  • 月経 span>

タイプ

  • 肉眼的血尿
  • 顕微鏡的血尿
  • 特発性血尿
  • ジョガーの血尿

エンド ユーザーによる

  • 病院
  • クリニック
  • 外来手術センター (ASC)
  • その他

国別

  • 北米
  • 米国
  • カナダ
  • メキシコ

記載されている企業

  • アストラゼネカ
  • ブリストル マイヤーズ スクイブ カンパニー
  • F.ホフマン・ラ・ロッシュ株式会社
  • グラクソ・スミスクライン plc.
  • ヤンセン・ファーマシューティカルズ
  • メルク&メルク社株式会社
  • ノバルティス AG
  • ファイザー株式会社
  • < span>サンファーマシューティカルインダストリーズ株式会社
  • ベーリンガーインゲルハイムインターナショナルGmbH 

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Hematuria Treatment Market – By Treatment

1.3.2        North America Hematuria Treatment Market – By Indication

1.3.3        North America Hematuria Treatment Market – By Type

1.3.4        North America Hematuria Treatment Market – By End User

1.3.5        North America Hematuria Treatment Market – By Country

2.           North America Hematuria Treatment Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Hematuria Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America – PEST Analysis

4.3         Experts Opinion

5.           Hematuria Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Prevalence of Hematuria-Associated Indications

5.1.2        Increasing Awareness About Treatment Options and Improving Healthcare Expenditure

5.2         Market Restraints

5.2.1        Undiagnosed Cases of Associated Indications

5.3         Market Opportunities

5.3.1        Increasing Opportunities for Related Treatments

5.4         Future Trends

5.4.1        Rise in Preference for Advanced Therapies

5.5         Impact Analysis

6.           Hematuria Treatment Market – North America Analysis

6.1         North America Hematuria Treatment Market Revenue Forecast and Analysis

7.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment

7.1         Overview

7.2         North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

7.3         Drugs

7.3.1        Overview

7.3.2        Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Therapies

7.4.1        Overview

7.4.2        Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Others

7.5.1        Overview

7.5.2        Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication

8.1         Overview

8.2         North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

8.3         Kidney Stones

8.3.1        Overview

8.3.2        Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Urinary Tract Infections (UTI)

8.4.1        Overview

8.4.2        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Urethritis

8.5.1        Overview

8.5.2        Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Blood Cancer

8.6.1        Overview

8.6.2        Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Bladder Stones

8.7.1        Overview

8.7.2        Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Prostate Cancer

8.8.1        Overview

8.8.2        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.9         Cystitis

8.9.1        Overview

8.9.2        Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.10      Trauma

8.10.1     Overview

8.10.2     Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.11      Vigorous Exercise

8.11.1     Overview

8.11.2     Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.12      Polycystic Kidney Disease

8.12.1     Overview

8.12.2     Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.13      Endometriosis

8.13.1     Overview

8.13.2     Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.14      Menstruation

8.14.1     Overview

8.14.2     Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

9.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Type

9.1         Overview

9.2         North America Hematuria Treatment Market, By Type 2020 & 2028 (%)

9.3         Macroscopic Hematuria

9.3.1        Overview

9.3.2        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.4         Microscopic Hematuria

9.4.1        Overview

9.4.2        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.5         Idiopathic Hematuria

9.5.1        Overview

9.5.2        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.6         Jogger’s Hematuria

9.6.1        Overview

9.6.2        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

10.        Hematuria Treatment Market Revenue and Forecast To 2028 – By End User

10.1      Overview

10.2      North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Clinics

10.4.1     Overview

10.4.2     Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.5      Ambulatory Surgical Centers (ASC’s)

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.6      Others

10.6.1     Overview

10.6.2     Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

11.        North America Hematuria Treatment Market – Geographic Analysis

11.1      North America: Hematuria Treatment Market

11.1.1     Overview

11.1.2     North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

11.1.2.1       US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1       US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2       US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.3       US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.4       US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.5       US: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.2.2       Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1       Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2       Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.3       Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.4       Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.5       Canada: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.2.3       Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1       Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2       Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.3       Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.4       Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.5       Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

12.        Impact Of COVID-19 Pandemic on Hematuria Treatment Market

12.1      North America: Impact Assessment of COVID-19 Pandemic

13.        Hematuria Treatment Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies Done by the Companies in the Market, (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        Company Profiles

14.1      AstraZeneca

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bristol-Myers Squibb Company

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      F. HOFFMANN-LA ROCHE LTD.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      GlaxoSmithKline Plc

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Janssen Pharmaceuticals

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Merck & Co., Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Novartis AG

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Pfizer Inc.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Sun Pharmaceutical Industries Ltd

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Boehringer Ingelheim International GmbH

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms


LIST OF TABLES

Table 1.             US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 2.             US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 3.             US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             US: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 5.             Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 6.             Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Canada: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 9.             Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 10.          Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 11.          Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Inorganic Developments Done by Companies

Table 15.          Glossary of Terms, Hematuria Treatment Market

 


LIST OF FIGURES

Figure 1.           Hematuria Treatment Market Segmentation

Figure 2.           North America Hematuria Treatment Market Overview

Figure 3.           Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market

Figure 4.           US to Show Significant Growth During Forecast Period

Figure 5.           North America Hematuria Treatment Market, Industry Landscape

Figure 6.           North America PEST Analysis

Figure 7.           Hematuria Treatment Market Impact Analysis of Drivers and Restraints

Figure 8.           North America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

Figure 10.        Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 11.        Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 12.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 13.        North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

Figure 14.        Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 15.        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 16.        Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 17.        Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 18.        Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 19.        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 20.        Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 21.        Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 22.        Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 23.        Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 24.        Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 25.        Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 26.        North America Hematuria Treatment Market, by Type 2020 & 2028 (%)

Figure 27.        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 28.        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 29.        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 30.        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 31.        North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)

Figure 32.        Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 33.        Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 34.        Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 35.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 36.        North America: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)

Figure 37.        North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

Figure 38.        US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        Impact Of COVID-19 Pandemic in North America Country Markets

Figure 42.        Growth Strategies Done by the Companies in the Market, (%)

  1. AstraZeneca
  2. Bristol-Myers Squibb Company
  3. F. HOFFMANN-LA ROCHE LTD.
  4. GlaxoSmithKline plc.
  5. Janssen Pharmaceuticals
  6. Merck & Co., Inc.
  7. Novartis AG
  8. Pfizer Inc.
  9. Sun Pharmaceutical Industries Ltd
  10. Boehringer Ingelheim International GmbH
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hematuria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000